The present invention relates to functional foods comprising DAO and their use for the prevention or treatment of diseases or pathological conditions associated with high levels of histamine in blood, in particular for the prevention or treatment of migraine, chronic fatigue, fibromyalgia, spondylitis and pain caused by muscle contractures.

The present invention relates to functional foods comprising DAO and their use for the prevention or treatment of diseases or pathological conditions associated with high levels of histamine in blood, in particular for the prevention or treatment of migraine, chronic fatigue, fibromyalgia, spondylitis and pain caused by muscle contractures.

A functional chemical consumption formulated for human consumption and useful for alleviating undesirable physiological effects. The chemical composition may be in liquid, food, or pill form and includes ingredients specifically to provide comfort for persons exposed to higher altitudes. Primary ingredients may include a combination of ammonium, chloride, and potassium ion.

A functional chemical consumption formulated for human consumption and useful for alleviating undesirable physiological effects. The chemical composition may be in liquid, food, or pill form and includes ingredients specifically to provide comfort for persons exposed to higher altitudes. Primary ingredients may include a combination of ammonium, chloride, and potassium ion.

A beverage or food additive for improving an individual's mental and physiological performance, the dietary composition comprising medium chain triglycerides oil, Ginko Biloba, Panax Ginseng, phosphatidylserine, Bacopa Monnieri, and Polygala Tenuifolia. In addition, the dietary composition may optionally contain docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and/or epigallocatechin gallate (EGCG).

A beverage or food additive for improving an individual's mental and physiological performance, the dietary composition comprising medium chain triglycerides oil, Ginko Biloba, Panax Ginseng, phosphatidylserine, Bacopa Monnieri, and Polygala Tenuifolia. In addition, the dietary composition may optionally contain docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and/or epigallocatechin gallate (EGCG).

Food products, such as a dough for producing a baked product, that contain Jerusalem artichoke flour, a flavor enhancer, and an anti-flatulence agent are disclosed. In certain embodiments, the food product is a baked product that is a cookie or cracker. In accordance with the subject matter of the disclosure, in certain embodiments, the food product contains at least 10 weight percent Jerusalem artichoke flour. The food product also may contain at least 1 weight percent of a flavor enhancer to mask the unpleasant aftertaste of the cynarin that is naturally present in the Jersualem artichoke flour. The food product additionally contains at least one anti-flatulence agent.

Food products, such as a dough for producing a baked product, that contain Jerusalem artichoke flour, a flavor enhancer, and an anti-flatulence agent are disclosed. In certain embodiments, the food product is a baked product that is a cookie or cracker. In accordance with the subject matter of the disclosure, in certain embodiments, the food product contains at least 10 weight percent Jerusalem artichoke flour. The food product also may contain at least 1 weight percent of a flavor enhancer to mask the unpleasant aftertaste of the cynarin that is naturally present in the Jersualem artichoke flour. The food product additionally contains at least one anti-flatulence agent.

The present invention relates to a composition comprising one or more fructanases and one or more Lactobacillus strains to provide relief from or prevent fructan and/or fructose induced abdominal discomfort; digest fructan and/or fructose or improve digestion of fructan and/or fructose; and/or provide digestive comfort after digestion of fructan and/or fructose on consumption of products containing fructan and/or fructose to a subject. The present invention also relates a Lactobacillus strain or a fructanse for providing relief from fructan and/or fructose induced abdominal discomfort to a subject, wherein the Lactobacillus strain in presence of one or more fructanases results in at least 20-50% reduction of gas pressure development, when tested against the fecal fermentation of the fiber alone across different donors.

The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.